Work Area: Private Antitrust Litigation

WATCH: GCR Connect: Germany

GCR Connect: Germany took place on 20 May. A full recording is now available to watch.

30 June 2021

Takeda and Endo hit with pay-for-delay claims

Takeda Pharmaceutical and Endo International are facing a lawsuit over an alleged scheme to block generic competition to Takeda’s branded anti-constipation drug Amitiza.

28 June 2021

CAT rejects mitigation defence in ball bearings cartel claim

The UK’s Competition Appeal Tribunal has refused to allow a member of the EU ball bearings cartel to argue that Fiat-Chrysler mitigated any loss it suffered as a result of the collusion by reducing supply costs for other goods and services.

24 June 2021

UK court sides with Google in Kelkoo disclosure dispute

A UK court has ruled that Google does not have to risk exposing business secrets by explaining each claim of confidentiality that it makes when disclosing information in a comparison shopping service’s standalone damages claim against it.

21 June 2021

Health authorities should have pushed alternative medication, Servier tells UK court

Servier has kicked off its bid to convince a UK court that national health authorities should have encouraged doctors to prescribe cheaper generic drugs to mitigate their losses from its pay-for-delay settlements relating to a blood pressure medication.

17 June 2021

Federal Circuit punts Walker-Process antitrust litigation to Fifth Circuit

The US Court of Appeals for the Federal Circuit has said it does not have jurisdiction to review litigation alleging that Phoenix Services’ assertion of a patent violated antitrust law.

11 June 2021

Epic urges Australian court to hear its competition claim

Epic Games has argued that allowing a California court to hear its Australian competition law claims against Apple would “defeat, restrict, limit or diminish” the intended purpose of the law and deprive Australians of the benefits of private enforcement actions.

09 June 2021

Quarantine hampers in-person evidence plans in Servier damages claim

A senior official at Servier may have to give evidence via videolink at a preliminary issues trial next week due to coronavirus restrictions, as the drugmaker seeks to prove that national health authorities in the UK should have mitigated any losses resulting from its alleged anticompetitive conduct.

09 June 2021

Get unlimited access to all Global Competition Review content